Case Control Study
Copyright ©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Jun 9, 2020; 11(2): 17-24
Published online Jun 9, 2020. doi: 10.4292/wjgpt.v11.i2.17
Table 3 Gastrointestinal symptoms in acromegaly patients compared with controls
Controls, n = 200 (%)Acromegaly patients, n = 50 (%)P value (Fisher’s exact test)
Oesophageal disorders
Functional chest pain2 (1%)3 (6%)0.0561
Functional heartburn22 (11%)15 (30%)0.0016b
Globus2 (1%)2 (4%)0.1796
Functional dysphagia4 (2%)6 (12%)0.0053b
Gastroduodenal disorders
Functional dyspepsia14 (7%)12 (24%)0.0013b
Belching disorders8 (4%)5 (10%)0.1441
Nausea and vomiting disorders2 (1%)2 (4%)0.1796
Rumination syndrome2 (1%)1 (2%)0.4895
Bowel disorders
Irritable bowel syndrome12 (6%)10 (20%)0.0041b
Functional constipation22 (11%)34 (68%)0.0006b
Functional diarrhoea10 (5%)9 (18%)0.0048b
Functional abdominal bloating/distension12 (6%)11 (22%)0.0015b
Unspecified functional bowel disorder44 (22%)25 (50%)0.0002b
Centrally mediated Abdominal pain syndrome6 (3%)4 (8%)0.1165
Functional Biliary pain1 (0.5%)3 (6%)0.0261a
Anorectal disorders
Faecal incontinence1 (0.5%)2 (4%)0.1028
Functional anorectal pain2 (1%)4 (8%)0.0157a